Unlike the effect of Foxp3+ Tregs, the role of cytotoxic CD8+ TILs in the setting of RCC has been controversial, with several studies demonstrating conflicting results [10, 18–22]. This evidence concerns the gene CD8A and renal cell carcinoma.